NDC 59746-211 – Cyclobenzaprine Hydrochloride
Cyclobenzaprine Hydrochloride 5 mg/1 · Tablet, Film Coated · Oral
Product NDC59746-211
Product details
- Brand name
- Cyclobenzaprine Hydrochloride
- Generic name
- Cyclobenzaprine Hydrochloride
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA077563
- Marketed since
- April 4, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Muscle Relaxant
Active ingredients
Uses, dosage, side effects and warnings for Cyclobenzaprine Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59746-211-06 | 100 TABLET, FILM COATED in 1 BOTTLE (59746-211-06) | Apr 4, 2006 |
| 59746-211-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (59746-211-10) | Apr 4, 2006 |
Other Cyclobenzaprine Hydrochloride products
- 50090-1848 Cyclobenzaprine Hydrochloride 7.5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-6864 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5713 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-4727 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-4730 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-4729 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5711 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5712 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-4722 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5756 Cyclobenzaprine Hydrochloride 5 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5772 Cyclobenzaprine Hydrochloride 10 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 72888-012 Cyclobenzaprine Hydrochloride 5 mg/1 · Tablet, Film Coated · Advagen Pharma Limited